{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:15:42Z","timestamp":1789773342736,"version":"4.0.1"},"reference-count":50,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T00:00:00Z","timestamp":1228867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>To evaluate the balance of interleukin <jats:italic>IL18<\/jats:italic> and its endogenous antagonist <jats:italic>IL18<\/jats:italic> binding protein (<jats:italic>IL18BP<\/jats:italic>) in patients with idiopathic thrombocytopenic purpura (ITP), plasma <jats:italic>IL18<\/jats:italic>, <jats:italic>IL18BP<\/jats:italic>, interferon gamma (<jats:italic>IFNG<\/jats:italic>) and <jats:italic>IL4<\/jats:italic> levels, as well as platelet counts were measured in patients with active ITP (<jats:italic>n\u2003<\/jats:italic>=\u200323), ITP in remission (<jats:italic>n\u2003<\/jats:italic>=\u200321) and in healthy subjects (<jats:italic>n\u2003<\/jats:italic>=\u200324) by enzyme linked immunosorbent assay (ELISA). Using real\u2010time quantitative polymerase chain reaction, the mRNA expression of <jats:italic>IL18<\/jats:italic>, <jats:italic>IL18BP<\/jats:italic>, <jats:italic>IFNG<\/jats:italic>, <jats:italic>IL4<\/jats:italic>, T\u2010box (<jats:italic>TBX21<\/jats:italic>) and GATA\u2010binding protein 3(<jats:italic>GATA3<\/jats:italic>) were studied in all subjects. The results showed that <jats:italic>IL18<\/jats:italic> and <jats:italic>IFNG<\/jats:italic> protein and mRNA levels were significantly increased in patients with active ITP than in control subjects, but that <jats:italic>IL18BP<\/jats:italic> were not significantly elevated in ITP patients, which resulted in an elevated ratio of <jats:italic>IL18\/IL18BP<\/jats:italic> in patients with active disease. During remission stages, the levels of these cytokines were comparable to those of healthy controls. The elevated levels of <jats:italic>IL18\/IL18BP<\/jats:italic> in plasma during active stages of disease suggest a possible role in the pathogenesis and course of ITP.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2008.07520.x","type":"journal-article","created":{"date-parts":[[2008,12,10]],"date-time":"2008-12-10T15:31:36Z","timestamp":1228923096000},"page":"755-761","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Interleukin 18 and interleukin 18 binding protein in patients with idiopathic thrombocytopenic purpura"],"prefix":"10.1111","volume":"144","author":[{"given":"Ning\u2010ning","family":"Shan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao\u2010juan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue\u2010wei","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong\u2010chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,1,27]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(99)00148-9"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.02.006"},{"key":"e_1_2_6_4_1","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1651-2227.1998.tb01237.x","article-title":"Cytokines in idiopathic thrombocytopenic purpura (ITP)","volume":"424","author":"Andersson J.","year":"1998","journal-title":"Acta Paediatrica Supplementum"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2100"},{"key":"e_1_2_6_6_1","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1182\/blood.V81.5.1246.1246","article-title":"Autoantibodies against platelet glycoproteins in autoimmune thrombocytopenic purpura: their clinical significance and response to treatment","volume":"81","author":"Berchtold P.","year":"1993","journal-title":"Blood"},{"key":"e_1_2_6_7_1","first-page":"224","article-title":"IL\u201018 in autoimmunity:review","volume":"17","author":"Boraschi D.","year":"2006","journal-title":"European Cytokine Network"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04131.x"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2005.04.009"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.1627"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1053\/tmrv.2003.50004"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115300"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.suppl_1.i17"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4718"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.3109\/07853899808999383"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0602313"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1191\/1352458504ms1071oa"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.262663399"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002770000177"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01911.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-005-4092-4"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.3.1190"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI4238"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ibd.20272"},{"key":"e_1_2_6_25_1","first-page":"303","article-title":"Imbalance of interleukin 18 and interleukin 18 binding protein in patients with lupus nephritis","volume":"4","author":"Liang D.","year":"2006","journal-title":"Cellular & Molecular Immunology"},{"key":"e_1_2_6_26_1","first-page":"89","article-title":"Elevated gene expression of Th1\/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus","volume":"34","author":"Lit L.C.W.","year":"2007","journal-title":"Rheumatology"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.9.4.532"},{"key":"e_1_2_6_28_1","first-page":"27","article-title":"Elevated systemic levels of free interleukin\u201018 (IL\u201018) in patients with Crohn\u2019s disease","volume":"16","author":"Ludwiczek O.","year":"2005","journal-title":"European Cytokine Network"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2003.024190"},{"key":"e_1_2_6_30_1","first-page":"1","article-title":"Relative expression software tool (REST\u00a9) for group\u2010wise comparison and statistical analysis of relative expression results in real\u2010time PCR","volume":"30","author":"Michael W.","year":"2002","journal-title":"Nucleic Acids Research"},{"key":"e_1_2_6_31_1","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.4049\/jimmunol.136.7.2348","article-title":"Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins","volume":"136","author":"Mosmann T.R.","year":"1986","journal-title":"Journal of Immunology"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.187.12.2103"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.19.1.423"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20011956"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80013-8"},{"key":"e_1_2_6_36_1","first-page":"116","article-title":"Interleukin\u201018 binding protein in the sera of patients with Wegener\u2019s granulomatosis","volume":"40","author":"Novick D.","year":"2008","journal-title":"Journal of Clinical Immunology"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2003.00138.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm921"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2268"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.3343\/kjlm.2007.27.2.128"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.167.12.7038"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI200112097"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.moh.0000141926.95319.42"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/1074-7613(95)90051-9"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V87.10.4245.bloodjournal87104245"},{"key":"e_1_2_6_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80702-3"},{"key":"e_1_2_6_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20014"},{"key":"e_1_2_6_48_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23186"},{"key":"e_1_2_6_49_1","first-page":"914","article-title":"Type 1 and Type 2 T\u2010cell profiles in idiopathic thrombocytopenic purpura","volume":"90","author":"Wang T.T.","year":"2005","journal-title":"Platelets"},{"key":"e_1_2_6_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0198-8859(01)00348-2"},{"key":"e_1_2_6_51_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0609.2000.9o096.x"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2008.07520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2008.07520.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T05:30:58Z","timestamp":1695965458000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2008.07520.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,27]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1365-2141.2008.07520.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2008.07520.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,27]]},"assertion":[{"value":"2009-01-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}